$APP

AppLovin shares drop on Bank of America downgrade

Bank of America downgraded AppLovin (APP) to Neutral, saying recent results raise uncertainty about sustaining its long-term 30% revenue growth target. It questioned whether self-learning drives sequential growth and said larger recommender models need more evidence. BofA cut its 2027 revenue growth to 23% and EBITDA to $8.3B, lowered the 2027 consumer forecast, and reduced its price target to $400 from $430.

Original reporting
Published Aug 11, 2026, 6:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AppLovin shares drop on Bank of America downgrade — source image
Decision brief

The 30-second read

$APPBearishMed
01

Why it matters

The note reduces 2027 revenue growth and EBITDA estimates and cuts the price objective, implying lower confidence in sustaining the long-term 30% revenue growth trajectory.

02

Market read

This is a concrete sell-side thesis update with forecast and price-target changes, driving immediate sentiment and valuation repricing.

03

What to watch

The downgrade hinges on evidence gaps for self-learning and recommender-model durability, but the article does not quantify execution progress or near-term catalysts that could validate the 30% target.

Relevance 7/10Novelty 6/10Timing: today after-hours/next-session repricing following the downgrade and PT cut

Background

Bank of America downgraded AppLovin to Neutral, arguing recent results challenge assumptions about the source of baseline sequential growth.

Company-level read

Ticker impact

$APPBearishHigh confidence
Context

AppLovin shares fell 5% after Bank of America downgraded it to Neutral, citing uncertainty around sustaining its 30% long-term revenue growth.

Expected impact

Near-term downside bias as traders reprice long-term growth assumptions and 2027 estimates.

Evidence & confidence

The article includes explicit changes to 2027 revenue growth, EBITDA, and the price objective, all tied to the downgrade thesis.

Market effects

Adtech growth expectations may face scrutiny if self-learning and recommender-model scaling evidence is deemed insufficient.

Limited, primarily impacts US adtech/growth-stock sentiment.

Limited direct global spillover; impacts investor perception of AI-driven adtech monetization durability.

Counterpoint

AppLovin may still be in an innovation transition where engineer-directed gaming model improvements and larger recommender models take time to show durable sequential growth.

Key entities

  • AppLovin Corp

    Subject of the downgrade; its long-term growth trajectory and 2027 estimates are questioned.

  • Bank of America

    Issued the downgrade to Neutral and lowered 2027 forecasts and price objective.

Related articles

$JBLMed

Stocks making the biggest moves midday: Jabil, AppLovin, Apollo, SpaceX, Upwork & more

Midday movers included Jabil, up 5% after a UBS upgrade to Buy, and AppLovin, down 5% after Bank of America downgraded to neutral and cut its price target to $400. Aramark rose 9% after Q3 beat and raised forecast. Under Armour fell 8% on a Barclays downgrade. Upwork dropped 13% on weaker guidance. Fermi jumped 22% after a first binding lease with TensorWave for 222 MW and about $6.5B contracted revenue.

$APPMedAI 8/10

Why is AppLovin stock sliding today?

AppLovin shares fell about 1.5% in pre-open trading to $333.84, near the 52-week low of $332.19. The company reported Q2 2026 revenue of $1.92B versus about $1.95B expected, and Q3 guidance midpoint around $2.075B, slightly below consensus. Multiple analysts cut targets and some downgraded after the earnings miss.

$APPMed

AppLovin Revenue Jumped 53%. So Why Did the Stock Just Plunge 20%?

AppLovin reported Q2 revenue of $1.92B, up 53% but slightly below the $1.94B analyst consensus, citing slower AI model improvement. Adjusted EPS rose 57% to $3.76 and adjusted EBITDA rose 58% to $1.6B. Free cash flow was $863.3M in Q2. Q3 revenue guidance was $2.055B-$2.085B. The stock fell about 20% after the results.